CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome
F Taube, JA Georgi, M Kramer, S Stasik… - Blood, The Journal …, 2022 - ashpublications.org
Biallelic mutations of the CEBPA gene (CEBPA bi) define a distinct entity associated with
favorable prognosis; however, the role of monoallelic mutations (CEBPA sm) is poorly …
favorable prognosis; however, the role of monoallelic mutations (CEBPA sm) is poorly …
[HTML][HTML] CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome
F Taube, JA Georgi, M Kramer, S Stasik, JM Middeke… - Blood, 2022 - Elsevier
Biallelic mutations of the CEBPA gene (CEBPA bi) define a distinct entity associated with
favorable prognosis; however, the role of monoallelic mutations (CEBPA sm) is poorly …
favorable prognosis; however, the role of monoallelic mutations (CEBPA sm) is poorly …
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome
F Taube, JA Georgi, M Kramer, S Stasik… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Biallelic mutations of the CEBPA gene (CEBPAbi) define a distinct entity associated with
favorable prognosis; however, the role of monoallelic mutations (CEBPAsm) is poorly …
favorable prognosis; however, the role of monoallelic mutations (CEBPAsm) is poorly …
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.
F Taube, JA Georgi, M Kramer, S Stasik, JM Middeke… - Blood, 2022 - europepmc.org
Biallelic mutations of the CEBPA gene (CEBPAbi) define a distinct entity associated with
favorable prognosis; however, the role of monoallelic mutations (CEBPAsm) is poorly …
favorable prognosis; however, the role of monoallelic mutations (CEBPAsm) is poorly …
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.
F Taube, JA Georgi, M Kramer, S Stasik, JM Middeke… - BLOOD, 2022 - pure.pmu.ac.at
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and
TAD mutations on outcome. — PMU Forschungsportal Zur Hauptnavigation wechseln Zur Suche …
TAD mutations on outcome. — PMU Forschungsportal Zur Hauptnavigation wechseln Zur Suche …
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome
F Taube, JA Georgi, M Kramer, S Stasik, JM Middeke… - Blood, 2022 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Biallelic mutations of the CEBPA gene
(CEBPAbi) define a distinct entity associated with favorable prognosis; however, the role of …
(CEBPAbi) define a distinct entity associated with favorable prognosis; however, the role of …
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.
F Taube, JA Georgi, M Kramer, S Stasik, JM Middeke… - BLOOD, 2022 - pure.pmu.ac.at
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and
TAD mutations on outcome. — PMU Research Portal Skip to main navigation Skip to search …
TAD mutations on outcome. — PMU Research Portal Skip to main navigation Skip to search …